Level Four Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.85M | Buy |
7,377
+188
| +3% | +$192K | 0.25% | 98 |
|
|
2026
Q1 | $6.61M | Buy |
7,189
+222
| +3% | +$225K | 0.22% | 127 |
|
|
2025
Q4 | $7.49M | Buy |
6,967
+825
| +13% | +$789K | 0.25% | 100 |
|
|
2025
Q3 | $4.69M | Sell |
6,142
-584
| -9% | -$435K | 0.16% | 174 |
|
|
2025
Q2 | $5.24M | Buy |
6,726
+283
| +4% | +$220K | 0.19% | 152 |
|
|
2025
Q1 | $5.32M | Sell |
6,443
-397
| -6% | -$330K | 0.22% | 140 |
|
|
2024
Q4 | $5.28M | Sell |
6,840
-2,053
| -23% | -$1.7M | 0.22% | 128 |
|
|
2024
Q3 | $7.38M | Buy |
8,893
+187
| +2% | +$168K | 0.31% | 74 |
|
|
2024
Q2 | $7.88M | Buy |
8,706
+1,964
| +29% | +$1.57M | 0.36% | 55 |
|
|
2024
Q1 | $3.93M | Hold |
6,742
| – | – | 0.22% | 122 |
|
|
2023
Q4 | $3.93M | Sell |
6,742
-61
| -0.9% | -$35.6K | 0.22% | 119 |
|
|
2023
Q3 | $3.65M | Sell |
6,803
-1,098
| -14% | -$566K | 0.24% | 112 |
|
|
2023
Q2 | $3.71M | Buy |
7,901
+707
| +10% | +$296K | 0.22% | 111 |
|
|
2023
Q1 | $2.47M | Sell |
7,194
-1,779
| -20% | -$600K | 0.16% | 151 |
|
|
2022
Q4 | $3.28M | Buy |
8,973
+3,262
| +57% | +$1.16M | 0.24% | 98 |
|
|
2022
Q3 | $1.85M | Buy |
5,711
+376
| +7% | +$119K | 0.18% | 136 |
|
|
2022
Q2 | $1.73M | Buy |
5,335
+1,077
| +25% | +$323K | 0.16% | 152 |
|
|
2022
Q1 | $1.22M | Buy |
4,258
+397
| +10% | +$102K | 0.1% | 213 |
|
|
2021
Q4 | $1.07M | Buy |
3,861
+601
| +18% | +$152K | 0.08% | 240 |
|
|
2021
Q3 | $753K | Sell |
3,260
-2,663
| -45% | -$657K | 0.08% | 220 |
|
|
2021
Q2 | $1.36M | Sell |
5,923
-3,358
| -36% | -$675K | 0.09% | 228 |
|
|
2021
Q1 | $1.73M | Buy |
9,281
+3,311
| +55% | +$648K | 0.13% | 170 |
|
|
2020
Q4 | $1.01M | Buy |
5,970
+195
| +3% | +$29.1K | 0.08% | 246 |
|
|
2020
Q3 | $855K | Sell |
5,775
-303
| -5% | -$46.9K | 0.07% | 267 |
|
|
2020
Q2 | $997K | Buy |
6,078
+1,591
| +35% | +$244K | 0.08% | 259 |
|
|
2020
Q1 | $623K | Sell |
4,487
-373
| -8% | -$51.3K | 0.07% | 278 |
|
|
2019
Q4 | $643K | Buy |
4,860
+187
| +4% | +$21.7K | 0.03% | 348 |
|
|
2019
Q3 | $523K | Sell |
4,673
-41
| -0.9% | -$4.57K | 0.05% | 316 |
|
|
2019
Q2 | $522K | Sell |
4,714
-414
| -8% | -$48.8K | 0.05% | 316 |
|
|
2019
Q1 | $665K | Sell |
5,128
-2,242
| -30% | -$273K | 0.07% | 263 |
|
|
2018
Q4 | $853K | Buy |
7,370
+423
| +6% | +$47.3K | 0.11% | 196 |
|
|
2018
Q3 | $746K | Buy |
6,947
+202
| +3% | +$20.2K | 0.08% | 256 |
|
|
2018
Q2 | $576K | Buy |
6,745
+1,886
| +39% | +$155K | 0.04% | 351 |
|
|
2018
Q1 | $376K | Sell |
4,859
-335
| -6% | -$27K | 0.03% | 397 |
|
|
2017
Q4 | $439K | Sell |
5,194
-429
| -8% | -$36.5K | 0.03% | 384 |
|
|
2017
Q3 | $481K | Sell |
5,623
-3,535
| -39% | -$290K | 0.04% | 348 |
|
|
2017
Q2 | $784K | Sell |
9,158
-191
| -2% | -$15.6K | 0.12% | 179 |
|
|
2017
Q1 | $800K | Buy |
9,349
+944
| +11% | +$75.6K | 0.08% | 240 |
|
|
2016
Q4 | $618K | Buy |
+8,405
| New | +$626K | 0.08% | 236 |
|
Other funds holding LLY
Level Four Advisory Services's LLY Position: Q2 2026 in Review
Level Four Advisory Services increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $192K and bringing the position to 7,377 shares worth $8.85M. The position accounts for 0.25% of the portfolio, ranked #98.
Level Four Advisory Services first reported a position in LLY in Q4 2016 and has held it in 39 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Level Four Advisory Services held 7,377 shares of Eli Lilly worth $8.85M as of Q2 2026.
- Level Four Advisory Services bought 188 Eli Lilly shares in Q2 2026, an estimated $192K.
- Eli Lilly made up 0.25% of Level Four Advisory Services's portfolio in Q2 2026, its #98 holding.
- Level Four Advisory Services first reported a position in Eli Lilly in Q4 2016 and has held it in 39 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.